Cardiovascular Diseases Clinical Trial
— CMCS-BeijingOfficial title:
Chinese Multi-provincial Cohort Study-Beijing Project
Verified date | December 2020 |
Source | Beijing Institute of Heart, Lung and Blood Vessel Diseases |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The Chinese Multi-provincial Cohort Study (CMCS)-Beijing project is a sub-study in CMCS participants from Beijing, which intended to investigate the progression and determinants of atherosclerosis and aging related health problems through repeat examinations. Exam 0 to Exam 3 have been conducted during 1992 to 2012. Exam 4 is scheduled in 2020.
Status | Enrolling by invitation |
Enrollment | 3000 |
Est. completion date | March 2021 |
Est. primary completion date | March 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 60 Years to 100 Years |
Eligibility | Inclusion Criteria: - Participants from CMCS-Beijing - sign the informed consent Exclusion Criteria: - participanting in clinical trials |
Country | Name | City | State |
---|---|---|---|
China | Beijing Sijiqing Hospital, Beijing | Beijing | |
China | Peking University Hospital, Beijing | Beijing | |
China | Peking University Shougang Hospital | Beijing |
Lead Sponsor | Collaborator |
---|---|
Beijing Institute of Heart, Lung and Blood Vessel Diseases |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | All fatal and nonfatal acute coronary and stroke events | Acute coronary heart disease events included acute myocardial infarction, sudden death, and other coronary deaths. Acute stroke events included subarachnoid hemorrhage, intracerebral hemorrhage, or cerebral infarction. | From date of enrollment until the date of first documented event or date of cardiovascular death, whichever came first, assessed at least 5 years | |
Secondary | New-onset of coronary events | Acute coronary heart disease events included acute myocardial infarction, sudden death, and other coronary deaths. | From date of enrollment until the date of first documented event or date of CHD death, whichever came first, assessed at least 5 years | |
Secondary | New-onset of stroke | Acute stroke events included subarachnoid hemorrhage, intracerebral hemorrhage, or cerebral infarction. | From date of enrollment until the date of first documented event or date of stroke death, whichever came first, assessed at least 5 years | |
Secondary | Total death | All cause death | From date of enrollment until date of death from all cause, assessed at least 5 years | |
Secondary | Cognitive dysfunction | Cognitive dysfunction | From date of enrollment until date of first documented event, assessed at least 5 years | |
Secondary | Olfactory Disorders | Olfactory Disorders | From date of enrollment until date of first documented event, assessed at least 5 years | |
Secondary | Valvular disease | Valvular disease | From date of enrollment until the date of first documented event or date of valvular disease death, whichever came first, assessed at least 5 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|
||
Completed |
NCT04098172 -
Evaluate the Performance and Safety of Comet Pressure Guidewire in the Measurement of FFR
|
N/A |